Department of Laboratory Medicine, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, The Netherlands.
Department of Pathology and Medical Biology, University Medical Center Groningen and University of Groningen, Groningen, The Netherlands.
Sci Rep. 2018 Jun 19;8(1):9353. doi: 10.1038/s41598-018-27107-8.
Iron is suggested to play a detrimental role in the progression of chronic kidney disease (CKD). The kidney recycles iron back into the circulation. However, the localization of proteins relevant for physiological tubular iron handling and their potential role in CKD remain unclear. We examined associations between iron deposition, expression of iron handling proteins and tubular injury in kidney biopsies from CKD patients and healthy controls using immunohistochemistry. Iron was deposited in proximal (PT) and distal tubules (DT) in 33% of CKD biopsies, predominantly in pathologies with glomerular dysfunction, but absent in controls. In healthy kidney, PT contained proteins required for iron recycling including putative iron importers ZIP8, ZIP14, DMT1, iron storage proteins L- and H-ferritin and iron exporter ferroportin, while DT only contained ZIP8, ZIP14, and DMT1. In CKD, iron deposition associated with increased intensity of iron importers (ZIP14, ZIP8), storage proteins (L-, H-ferritin), and/or decreased ferroportin abundance. This demonstrates that tubular iron accumulation may result from increased iron uptake and/or inadequate iron export. Iron deposition associated with oxidative injury as indicated by heme oxygenase-1 abundance. In conclusion, iron deposition is relatively common in CKD, and may result from altered molecular iron handling and may contribute to renal injury.
铁被认为在慢性肾脏病(CKD)的进展中起有害作用。肾脏将铁回收回循环中。然而,与生理管状铁处理相关的蛋白质的定位及其在 CKD 中的潜在作用仍不清楚。我们使用免疫组织化学检查了 CKD 患者和健康对照者的肾活检中铁沉积、铁处理蛋白表达与管状损伤之间的关联。铁沉积在 CKD 活检的 33%的近端(PT)和远端(DT)肾小管中,主要存在于肾小球功能障碍的病变中,但在对照组中不存在。在健康肾脏中,PT 含有铁回收所需的蛋白质,包括推定的铁摄取体 ZIP8、ZIP14、DMT1、铁储存蛋白 L-和 H-铁蛋白和铁输出蛋白 ferroportin,而 DT 仅含有 ZIP8、ZIP14 和 DMT1。在 CKD 中,铁沉积与铁摄取体(ZIP14、ZIP8)、储存蛋白(L-、H-铁蛋白)的强度增加和/或 ferroportin 丰度降低相关。这表明管状铁积累可能是由于铁摄取增加和/或铁输出不足所致。铁沉积与血红素加氧酶-1丰度增加引起的氧化损伤相关。总之,铁沉积在 CKD 中较为常见,可能是由于分子铁处理改变所致,并可能导致肾脏损伤。